Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Camp4 Therapeutics (CAMP) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to 1899.25%.

  • Camp4 Therapeutics' EBITDA Margin changed N/A to 1899.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 1404.47%, marking a year-over-year change of. This contributed to the annual value of 7943.4% for FY2024, which is 61397400.0% up from last year.
  • Latest data reveals that Camp4 Therapeutics reported EBITDA Margin of 1899.25% as of Q3 2025.
  • In the past 5 years, Camp4 Therapeutics' EBITDA Margin registered a high of 840.81% during Q2 2025, and its lowest value of 3341.71% during Q3 2023.
  • For the 3-year period, Camp4 Therapeutics' EBITDA Margin averaged around 1913.5%, with its median value being 1899.25% (2025).